Cargando…

Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

BACKGROUND: Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status. METHODS: We studied 160 patients with CAD and 169 subjects with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Sabrina H, McQuarrie, Emily P, Miller, William H, Mackenzie, Ruth M, Dymott, Jane A, Moreno, María U, Taurino, Chiara, Miller, Ashley M, Neisius, Ulf, Berg, Geoffrey A, Valuckiene, Zivile, Hannay, Jonathan A, Dominiczak, Anna F, Delles, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751647/
https://www.ncbi.nlm.nih.gov/pubmed/23937620
http://dx.doi.org/10.1186/1471-2369-14-173
_version_ 1782281641113157632
author Rossi, Sabrina H
McQuarrie, Emily P
Miller, William H
Mackenzie, Ruth M
Dymott, Jane A
Moreno, María U
Taurino, Chiara
Miller, Ashley M
Neisius, Ulf
Berg, Geoffrey A
Valuckiene, Zivile
Hannay, Jonathan A
Dominiczak, Anna F
Delles, Christian
author_facet Rossi, Sabrina H
McQuarrie, Emily P
Miller, William H
Mackenzie, Ruth M
Dymott, Jane A
Moreno, María U
Taurino, Chiara
Miller, Ashley M
Neisius, Ulf
Berg, Geoffrey A
Valuckiene, Zivile
Hannay, Jonathan A
Dominiczak, Anna F
Delles, Christian
author_sort Rossi, Sabrina H
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status. METHODS: We studied 160 patients with CAD and 169 subjects without CAD. The 4-variable MDRD formula was used to estimate glomerular filtration rate (eGFR); impaired renal function was defined as eGFR <60 mL/min. Carotid-femoral pulse wave velocity (PWV) was measured with the SphygmoCor® device. Circulating biomarkers were assessed in plasma using xMAP® multiplexing technology. RESULTS: Patients with CAD and impaired renal function had greater PWV compared to those with CAD and normal renal function (10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s; P < 0.001). In all patients, PWV was a function of eGFR (β = −0.293; P < 0.001) even after adjustment for age, sex, systolic blood pressure, body mass index and presence or absence of CAD. Patients with CAD and impaired renal function had higher levels of adhesion and inflammatory molecules including E-selectin and osteopontin (all P < 0.05) compared to those with CAD alone, but had similar levels of markers of oxidative stress. CONCLUSIONS: Renal function is a determinant of vascular stiffness even in patients with severe atherosclerotic disease. This was paralleled by differences in markers of cell adhesion and inflammation. Increased vascular stiffness may therefore be linked to inflammatory remodeling of the vasculature in people with impaired renal function, irrespective of concomitant atherosclerotic disease.
format Online
Article
Text
id pubmed-3751647
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37516472013-08-24 Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease Rossi, Sabrina H McQuarrie, Emily P Miller, William H Mackenzie, Ruth M Dymott, Jane A Moreno, María U Taurino, Chiara Miller, Ashley M Neisius, Ulf Berg, Geoffrey A Valuckiene, Zivile Hannay, Jonathan A Dominiczak, Anna F Delles, Christian BMC Nephrol Research Article BACKGROUND: Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status. METHODS: We studied 160 patients with CAD and 169 subjects without CAD. The 4-variable MDRD formula was used to estimate glomerular filtration rate (eGFR); impaired renal function was defined as eGFR <60 mL/min. Carotid-femoral pulse wave velocity (PWV) was measured with the SphygmoCor® device. Circulating biomarkers were assessed in plasma using xMAP® multiplexing technology. RESULTS: Patients with CAD and impaired renal function had greater PWV compared to those with CAD and normal renal function (10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s; P < 0.001). In all patients, PWV was a function of eGFR (β = −0.293; P < 0.001) even after adjustment for age, sex, systolic blood pressure, body mass index and presence or absence of CAD. Patients with CAD and impaired renal function had higher levels of adhesion and inflammatory molecules including E-selectin and osteopontin (all P < 0.05) compared to those with CAD alone, but had similar levels of markers of oxidative stress. CONCLUSIONS: Renal function is a determinant of vascular stiffness even in patients with severe atherosclerotic disease. This was paralleled by differences in markers of cell adhesion and inflammation. Increased vascular stiffness may therefore be linked to inflammatory remodeling of the vasculature in people with impaired renal function, irrespective of concomitant atherosclerotic disease. BioMed Central 2013-08-13 /pmc/articles/PMC3751647/ /pubmed/23937620 http://dx.doi.org/10.1186/1471-2369-14-173 Text en Copyright © 2013 Rossi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rossi, Sabrina H
McQuarrie, Emily P
Miller, William H
Mackenzie, Ruth M
Dymott, Jane A
Moreno, María U
Taurino, Chiara
Miller, Ashley M
Neisius, Ulf
Berg, Geoffrey A
Valuckiene, Zivile
Hannay, Jonathan A
Dominiczak, Anna F
Delles, Christian
Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
title Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
title_full Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
title_fullStr Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
title_full_unstemmed Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
title_short Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
title_sort impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751647/
https://www.ncbi.nlm.nih.gov/pubmed/23937620
http://dx.doi.org/10.1186/1471-2369-14-173
work_keys_str_mv AT rossisabrinah impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT mcquarrieemilyp impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT millerwilliamh impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT mackenzieruthm impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT dymottjanea impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT morenomariau impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT taurinochiara impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT millerashleym impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT neisiusulf impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT berggeoffreya impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT valuckienezivile impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT hannayjonathana impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT dominiczakannaf impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease
AT delleschristian impairedrenalfunctionimpactsnegativelyonvascularstiffnessinpatientswithcoronaryarterydisease